Mountfield RJ[au] - Search Results

Year	Number of Results
1998	1
2000	6
2001	1
2002	2
2022	0

1

Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters.

Bittner B, Mountfield RJ. Bittner B, et al. Among authors: mountfield rj. Curr Opin Drug Discov Devel. 2002 Jan;5(1):59-71. Curr Opin Drug Discov Devel. 2002. PMID: 11865674 Review.

2

Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450.

Mountfield RJ, Senepin S, Schleimer M, Walter I, Bittner B. Mountfield RJ, et al. Int J Pharm. 2000 Dec 15;211(1-2):89-92. doi: 10.1016/s0378-5173(00)00586-x. Int J Pharm. 2000. PMID: 11137342

3

Metabolism of levormeloxifene, a selective oestrogen receptor modulator, in the Sprague-Dawley rat, Cynomolgus monkey and postmenopausal woman.

Mountfield RJ, Panduro AM, Wassmann O, Thompson M, John B, van der Merbel N. Mountfield RJ, et al. Xenobiotica. 2000 Feb;30(2):201-17. doi: 10.1080/004982500237785. Xenobiotica. 2000. PMID: 10718126

4

Metabolism, disposition, excretion, and pharmacokinetics of levormeloxifene, a selective estrogen receptor modulator, in the rat.

Mountfield RJ, Kiehr B, John BA. Mountfield RJ, et al. Drug Metab Dispos. 2000 May;28(5):503-13. Drug Metab Dispos. 2000. PMID: 10772628

5

Selective and potent inhibition of human CYP2C19 activity by a conformationally targeted antipeptide antibody.

Schulz-Utermoehl T, Mountfield RJ, Madsen K, Jørgensen PN, Hansen KT. Schulz-Utermoehl T, et al. Among authors: mountfield rj. Drug Metab Dispos. 2000 Jul;28(7):715-7. Drug Metab Dispos. 2000. PMID: 10859141

6

The impact of co-solvents and the composition of experimental formulations on the pump rate of the ALZET osmotic pump.

Bittner B, Thelly T, Isel H, Mountfield RJ. Bittner B, et al. Among authors: mountfield rj. Int J Pharm. 2000 Sep 15;205(1-2):195-8. doi: 10.1016/s0378-5173(00)00481-6. Int J Pharm. 2000. PMID: 11000556

7

Improvement of the bioavailability of colchicine in rats by co-administration of D-alpha-tocopherol polyethylene glycol 1000 succinate and a polyethoxylated derivative of 12-hydroxy-stearic acid.

Bittner B, Guenzi A, Fullhardt P, Zuercher G, González RC, Mountfield RJ. Bittner B, et al. Among authors: mountfield rj. Arzneimittelforschung. 2002;52(9):684-8. doi: 10.1055/s-0031-1299951. Arzneimittelforschung. 2002. PMID: 12404883

8

The formation of 1-hydroxymethylnaphthalene and 6-hydroxymethylquinoline by both oxidative and reductive routes in Cunninghamella elegans.

Mountfield RJ, Hopper DJ. Mountfield RJ, et al. Appl Microbiol Biotechnol. 1998 Sep;50(3):379-83. doi: 10.1007/s002530051308. Appl Microbiol Biotechnol. 1998. PMID: 9802224

9

Structure-function analysis of human CYP3A4 using a specific proinhibitory antipeptide antibody.

Schulz-Utermoehl T, Mountfield RJ, Bywater RP, Madsen K, Jørgensen PN, Hansen KT. Schulz-Utermoehl T, et al. Among authors: mountfield rj. Drug Metab Dispos. 2000 Jul;28(7):718-25. Drug Metab Dispos. 2000. PMID: 10859142

10

The use of election paramagnetic resonance spectroscopy in early preformulation experiments: the impact of different experimental formulations on the release of a lipophilic spin probe into gastric juice.

Bittner B, Isel H, Mountfield RJ. Bittner B, et al. Among authors: mountfield rj. Eur J Pharm Biopharm. 2001 Mar;51(2):159-62. doi: 10.1016/s0939-6411(00)00151-x. Eur J Pharm Biopharm. 2001. PMID: 11226824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results